REVISION FORMULA Sample Clauses

REVISION FORMULA. In determining the revised Reference Price, ECIn and ICn shall be calculated to the nearest tenth (1 decimal). Each quotient ***** (4 decimals). ***** Confidential portions of the material have been omitted and filed separately with the Securities and Exchange Commission. EXHIBIT H-2 PROPULSION SYSTEMS PRICE REVISION FORMULA INTERNATIONAL AERO ENGINES If the next succeeding place is five (5) or more the preceding decimal place shall be raised to the next higher figure. After final computation Pn shall be rounded to the nearest whole number (0.5 rounds to 1)
Sample 1Sample 2
AutoNDA by SimpleDocs
REVISION FORMULA. Pn = (Pb + F) x [([***] x (HEn/HEb)) + ([***] x (ICn/ICb))] Where :
Sample 1
REVISION FORMULA. Pn = (Pb + F) x [(***** x (ECIn/ECIb)) + (***** x (MMPn/MMPb)) + (0.10 x (EPn/EPb))] Where :
Sample 1
REVISION FORMULA. Pn = (Pb + F) x [(***** x (ECIn/ECIb)) + (***** x (MMPn/MMPb)) + (***** x (EPn/EPb))] where : F : (0.005 x N x Pb) where N is the calendar year of Aircraft Delivery minus 2001 Pn : revised XX Xxxxx 772B Reference Price of a set of two Propulsion Systems at Aircraft Delivery Pb : XX Xxxxx 772B Reference Price at averaged economic conditions December 1999, January 2000, February 2000 ECIn : ECI336411W Index for 13th, 12th, 11th months averaged prior to the month of Aircraft Delivery ECIb : ECI336411W Index for December 1999, January 2000, February 2000 averaged (=81.80) MMPn : MMP-Index for the 13th, 12th, 11th months averaged prior to the month of Aircraft Delivery MMPb : MMP-Index for December 1999, January 2000, February 2000 averaged (=128.13) EPn : EP-Index for the 13th, 12th, 11th months averaged prior to the month of Aircraft Delivery EPb : EP-Index for December 1999, January 2000, February 2000 averaged (=89.50) Intrepid – Airbus A330-200F PA Amendment 3 –ref #CT0903391 EXECUTION CONFIDENTIAL AND PRIVILEGED 47/53 ***** Confidential portions of the material have been omitted and filed separately with the Securities and Exchange Commission.
Sample 1
REVISION FORMULA. Pn = (Pb + F) x [([***] (ECIn/EClb)) + ([***] (lCn/lCb))] Where : Pn : Airframe Basic Price as revised at the Delivery Date of the Aircraft Pb : Airframe Basic Price at economic conditions December 2004, January 2005, February 2005 averaged (January 2006 delivery conditions) F : ([***] x N x Pb) where N = the calender year of Delivery of the Aircraft minus 2006 ECIn : the arithmetic average of the latest published values of the [***] available at the Delivery Date of the Aircraft for the 11th, 12th and 13th month prior to the month of Aircraft Delivery ECIb : [***] for December 2004, January 2005, February 2005 averaged (=[***])
Sample 1
REVISION FORMULA. Pn : (Pb + F) x (CPIn/[***]) where : Pn : revised Reference Price at Aircraft Delivery. Pb : Reference Price at delivery conditions January 2003 F : ([***] x N x Pb) where N = the calendar year of Delivery of the Aircraft minus 2003 CPIn : the Composite Price Index (CPI) applicable for the month of Aircraft Delivery. This Composite Price Index is composed as follows : CPIn= ([***] x ECIn) + ([***] x Icn) where :
Sample 1
REVISION FORMULA. Pn = Pb x [(***ECIn)/ECIb + (*** MMPn)/MMPb + (*** Epn)/EPb] Where : Pn : revised Reference Price at Aircraft Delivery Pb : Reference Price at averaged economic conditions February 2001 ECIn : ECIsic3721W Index for the fourth month prior to the month of Aircraft Delivery ECIb : HE SIC 3721W for June 2001 (=154.3) MMPn : MMP-Index for the fourth month prior to the month of Aircraft Delivery MMPb : MMP-Index for June 2001 (=126.6)
Sample 1
AutoNDA by SimpleDocs

Related to REVISION FORMULA

  • Revision Manager may revise the Operating Budget from time to time, as necessary, to reflect any unpredicted significant changes, variables or events or to include significant additional, unanticipated items of revenue and expense. Any such revision shall be submitted to Owner for approval, which approval shall not be unreasonably withheld, delayed or conditioned.

  • Development Schedule The Project shall substantially comply with the specific timetables and triggers for action set forth in Article 5 of this Agreement. The parties acknowledge that, as provided in G.S. 160A-400.25(b), the failure to meet a commencement or completion date shall not, in and of itself, constitute a material breach of this Agreement pursuant to G.S. 160A-400.27 but must be judged based upon the totality of the circumstances.

  • Revisions With respect to Contracts that are “electronic chattel paper”, the related Receivables have been established in a manner such that (a) all copies or revisions that add or change an identified assignee of the authoritative copy of each such Contract must be made with the participation of the Trust Collateral Agent and (b) all revisions of the authoritative copy of each such Contract are readily identifiable as an authorized or unauthorized revision.

  • Acceptance Criteria 6.7.2.1. During the test there shall be no evidence of:

  • Formula The formula referred to in paragraph 3.1 is as follows: = ∑�( + )●●●� where:

  • Selection Criteria Each Contract is secured by a new or used Motorcycle. No Contract has a Contract Rate less than 1.00%. Each Contract amortizes the amount financed over an original term no greater than 84 months (excluding periods of deferral of first payment). Each Contract has a Principal Balance of at least $500.00 as of the Cutoff Date.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

  • Payment Schedule Except as provided in section 6.10 Travel, Meals and Lodging, payments will only be made based on Deliverables outlined within the Authorized User Agreement. Any invoice not related directly to a completed deliverable will be rejected. Any charge included on the invoice without backup documentation as specified in the Authorized User Agreement (travel receipts, etc.) may be removed. Any outstanding charges un-invoiced or removed from the invoice must be submitted/resubmitted within 120 Calendar days or may not be reimbursed. Each Deliverable may contain a retainage allotment as specified within the Authorized User Agreement. Each invoice is to include a detailed and itemized list of all retainage withholds that are in place since the activation of the Authorized User Agreement. Payment schedule shall be based on the final Authorized User Agreement as negotiated by the Authorized User and Contractor. Payment is only to be made after the deliverable within the Authorized User Agreement is accepted by the Authorized User. A Contractor is encouraged to submit no more than one invoice per month. Invoices must include cumulative retainage holdback. Invoices submitted to an Authorized User must include backup documentation as defined in the negotiated Authorized User Agreement.

  • Specification Changes Upon any change in the Product Specifications, stability protocols, QC laboratory methods raw material specification or Packaging Specifications (whether initiated by Horizon or made in response to a request by sanofi-aventis that is agreed to by Horizon), including the addition of new packaging configurations, new SKUs, new formulations, or a change in either raw materials or Packaging Component supply, Horizon shall promptly advise sanofi-aventis in writing of such changes, and sanofi-aventis shall promptly advise Horizon as to any scheduling and/or price adjustments which may result from such changes. Prior to implementation of such changes, the Parties shall negotiate in good faith in an attempt to reach agreement on (a) the new Product Price for any Product which embodies such changes, (b) any amounts to be reimbursed by Horizon to sanofi-aventis as described in the next sentence of this paragraph, and (c) any other amendments to this Agreement which may be necessitated by such changes (i.e., an adjustment to the lead time for purchase orders). Horizon shall reimburse sanofi-aventis for the mutually agreed upon reasonable expenses incurred by sanofi-aventis as a result of such changes, including, but not limited to, reimbursing sanofi-aventis for its mutually agreed validation and development costs, capital expenditure costs, costs for any Packaging Components or other materials rendered unusable as a result of such changes, and cost of required stability to support a change. If during the Term Horizon amends the Product Specifications or Packaging ***Confidential Treatment Requested MANUFACTURING AND SUPPLY AGREEMENT PAGE 7 Specifications (whether voluntarily or as required by law) so as to render obsolete quantities of the Active Ingredient, Excipients and/or Packaging Components for the Product on hand at sanofi-aventis, Horizon shall (i) accept the return of all such obsolete Active Ingredient and (ii) purchase from sanofi-aventis, at sanofi-aventis’ Acquisition Cost, all such obsolete Excipients and Packaging Components obtained by sanofi-aventis pursuant to its normal procurement policies to manufacture quantities of the Product pursuant to Horizon forecasts under Section 6.1. Sanofi-aventis’ normal procurement policies for purposes of the preceding sentence of this Article 5 shall be considered to be quantities of Excipients and Packaging Components corresponding to the immediately following […***…] months of Horizon’s most recent forecasted Product demand. If a change in Specifications is initiated by sanofi-aventis and approved by Horizon, any cost associated with said change shall be borne by sanofi-aventis. In the event that a change in Specifications is initiated by Horizon or driven by a regulatory or business change, the costs associated with qualification of the change shall be paid by Horizon. The amount of the change shall be reasonable and customary and subject to written approval by Horizon, such approval not to be unreasonably withheld. Sanofi-aventis, with written agreement and approval from Horizon, will be responsible for the appropriate (cGMP) destruction of any materials covered under this Article 5, and sanofi-aventis shall be reimbursed by Horizon at the reasonable and customary approved rate.

Time is Money Join Law Insider Premium to draft better contracts faster.